Therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: Biology, clinical results and future development Journal Article

  

Authors:	Rini, B. I.; Sosman, J. A.; Motzer, R. J.
Article Title:	Therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: Biology, clinical results and future development
Keywords:	vasculotropin; vascular endothelial growth factor a; clinical trial; fatigue; review; sorafenib; bevacizumab; erlotinib; sunitinib; diarrhea; hypertension; side effect; antineoplastic agents; benzenesulfonates; pyridines; drug targeting; alpha interferon; gene; imatinib; interleukin 2; metastasis; gene expression; nausea; stomatitis; vasculotropin inhibitor; kidney carcinoma; kidney neoplasms; temsirolimus; asthenia; lymphocytopenia; rash; antibodies, monoclonal; carcinoma, renal cell; thromboembolism; pancreatitis; gefitinib; gene inactivation; vhl gene; indoles; pyrroles; hand foot syndrome; vasculotropin antibody; proteinuria; epidermal growth factor receptor antibody; clinical trials; vegf; hemoptysis; recombinant alpha2a interferon; recombinant alpha2b interferon; rcc; su11248; vhl; bay 43-9006
Journal Title:	BJU International
Volume:	96
Issue:	3
ISSN:	1464-4096
Publisher:	Wiley Blackwell
Date Published:	2005-08-01
Start Page:	286
End Page:	290
Language:	English
DOI:	10.1111/j.1464-410X.2005.05616.x
PUBMED:	16042715
PROVIDER:	scopus
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-23244458246&partnerID=40&md5=2dc77d6c01cf195b6dfeee162a38466d
Notes:	--- - "Cited By (since 1996): 34" - "Export Date: 24 October 2012" - "CODEN: BJINF" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/35744